These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3136278)

  • 1. The role of aldose reductase in the development of diabetic complications.
    Kador PF
    Med Res Rev; 1988; 8(3):325-52. PubMed ID: 3136278
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 4. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
    Kinoshita JH
    Am J Ophthalmol; 1986 Dec; 102(6):685-92. PubMed ID: 3098107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aldose reductase in the development of diabetes-associated complications.
    Kador PF; Kinoshita JH
    Am J Med; 1985 Nov; 79(5A):8-12. PubMed ID: 3934965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase in the etiology of diabetic complications: 2. Nephropathy.
    Stribling D; Armstrong FM; Harrison HE
    J Diabet Complications; 1989; 3(2):70-6. PubMed ID: 2526143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunohistologic localization of aldose reductase in the human eye by monoclonal antibodies].
    Jahn CE; Schindler E; Holbach L; Kador PF
    Fortschr Ophthalmol; 1984; 81(5):433-5. PubMed ID: 6437949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus.
    Hamada Y; Kitoh R; Raskin P
    Diabet Med; 1993; 10(1):33-8. PubMed ID: 8435985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase in the etiology of diabetic complications. 3. Neuropathy.
    Stribling D; Armstrong FM; Perkins CM; Smith JC
    J Diabet Complications; 1989; 3(3):139-48. PubMed ID: 2528557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF; Kinoshita JH; Sharpless NE
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract]   [Full Text] [Related]  

  • 16. The involvement of aldose reductase in diabetic complications.
    Kinoshita JH; Nishimura C
    Diabetes Metab Rev; 1988 Jun; 4(4):323-37. PubMed ID: 3134179
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldose reductase in the etiology of diabetic complications: I. Introduction.
    Harrison HE; Stribling D; Armstrong FM; Perkins CM
    J Diabet Complications; 1989; 3(1):6-11. PubMed ID: 2540215
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?
    Frank RN
    Arch Ophthalmol; 1990 Sep; 108(9):1229-31. PubMed ID: 2119167
    [No Abstract]   [Full Text] [Related]  

  • 19. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
    Kador PF; Kinoshita JH
    Diabet Med; 1985 May; 2(3):187-9. PubMed ID: 2952417
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.